Unilever faces investor revolt over new chief's pay package
Unilever, the FTSE-100 consumer goods giant behind Marmite and Lynx, is facing an investor backlash over its new chief executive's multimillion pound pay package.
Sky News has learnt that ISS, a leading proxy adviser, has recommended that shareholders vote against Unilever's remuneration report at its annual meeting later this month.
Sources familiar with ISS's report on Unilever's AGM resolutions say the agency objects to the discount of just €50,000 that the Ben & Jerry's owner has applied to the base salary of Fernando Fernandez, compared to Hein Schumacher, his predecessor.
Tariffs latest: Trump claimed world was 'kissing my a**' for deals
Unilever surprised the City in February when it announced that Mr Schumacher would leave after just two years in the job, amid frustration in its boardroom about the pace of growth.
In an accompanying statement, Unilever said Mr Fernandez - previously the chief financial officer - would be paid a basic salary of €1.8m, modestly lower than Mr Schumacher's €1.85m.
In a summary of ISS's report, the proxy adviser said Mr Fernandez's "base salary as new CEO is significant and represents a small discount to the former CEO Hein Schumacher's base salary".
"The company does not appear to have sufficiently accounted previously raised shareholder concerns on the CEO role's pay arrangement when setting Mr Fernandez's remuneration."
Unilever had also "disapplied time pro-rating" in respect of former executive directors' long-term share awards, meaning that the company could have legitimately decided to award them smaller amounts of stock than it did.
On Wednesday afternoon, shares in Unilever were trading at around £44.79, giving the maker of Magnum ice cream and Persim washing-up liquid a valuation of close to £115bn.
Unilever did not respond to a request for comment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Penn Entertainment responds to ISS report
Penn Entertainment (PENN) made the following statement in response to the report issued by Institutional Shareholder Services related to the company's 2025 annual meeting of shareholders on June 17: 'The ISS report confirms that two director seats are up for election at the 2025 Annual Meeting and that PENN and HG Vora have nominated and are recommending the same two highly-qualified candidates – Johnny Hartnett and Carlos Ruisanchez. ISS recognizes the open-mindedness with which PENN evaluated HG Vora's director candidates, noting: 'To its credit, the board appears to have given serious consideration to all three dissident nominees, and was open to accepting two of these nominees as its own.' PENN encourages all shareholders to vote for Messrs. Hartnett and Ruisanchez for election and looks forward to welcoming them to the Board. Following the Annual Meeting, 75% of PENN's directors will have joined the Board since 2019. In reaching its conclusions however, the ISS report fails to reflect a realistic view of William Clifford's candidacy. We remind shareholders that, during his time as PENN's CFO, Mr. Clifford advocated against key initiatives that were critical to succeeding in a competitive market. Following Mr. Clifford's departure in 2013 as PENN's CFO, these changes were implemented under the publicly announced P30 program and resulted in meaningful margin improvement. Further, during his interviews with PENN's Nominating and Corporate Governance Committee, Mr. Clifford demonstrated antiquated views of a rapidly changing industry, and the same posture of resistance to exploring value-generating solutions, which we believe would hinder constructive decision-making. PENN attempted multiple resolutions with HG Vora, but all of our resolution attempts were rejected. Given HG Vora's violation of its institutional waivers by multiple state gaming regulators, our ability to allow HG Vora to influence the governance of the Company beyond the evaluation of the nominees was expressly prohibited. We appreciate the feedback and advice we have received from our shareholders in advance of this year's Annual Meeting. We want to assure shareholders that we understand and share their focus on ensuring that PENN's Board of Directors is optimally comprised to oversee the Company's execution on a strategic plan to drive shareholder value. The Board and management team remain committed to creating value for all shareholders and will continue to take actions in support of that objective.'
Business Insider
3 hours ago
- Business Insider
Opening Day: Stablecoin issuer Circle soars in public debut
Shares of Circle jumped almost 170% in their trading debut after the stablecoin company raised about $1.1B in its IPO. The stock opened at $69 after the pure-play crypto company priced its initial public offering at $31 per share. Confident Investing Starts Here: Two other big names are next, with IPOs expected next week. Fintech Chime and space and defense company Voyager Technologies are expected to go public sometime in the week of June 9. Omada Health (OMDA) opened on June 6 at $23. The company that bills itself as 'the virtual between-visit healthcare provider' priced 7.9M shares at $19.00, in the middle of the $18.00-$20.00 range. Circle (CRCL) opened on June 5 at $69.00. The company priced its upsized initial public offering of 34M shares at a public offering price of $31.00 per share. Circle is a financial technology firm that enables businesses 'to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide.' END OF THE WEEK PERFORMANCE: Omada Health – up almost 31% at $24.80. Circle – up about 42% at $117.25. RECENT IPOS TO WATCH: Arrive AI (ARAI), eToro (ETOR), Antalpha (ANTA), and OMS Energy (OMSE) are among stocks that could see new coverage roll out this upcoming week as the quiet periods for banks that underwrote the companies' IPOs expire. Click here to see upcoming IPO calendar on TipRanks. Voyager Technologies filed with the SEC for an initial public offering of shares of Class A common stock. The company said it intends to apply to list its Class A common stock on the New York Stock Exchange under the symbol 'VOYG.' The prospectus states, 'We are an innovation-driven defense technology and space solutions company. Our company was purpose-built to address issues at the forefront of defense, national security and space industries and we have organized our business to reflect this goal. We strive to solve complex challenges to fortify national security, protect critical assets and unlock new frontiers for human progress and economic development. We are committed to developing and delivering an array of transformative, mission-critical solutions to customers enabled by our advanced technology, analytics and space infrastructure capabilities. Our solutions include communications and intelligence collection systems, defense systems, advanced space technology, in-space infrastructure and space mission services. Our business consists of diversified solutions across three business segments: Defense & National Security, Space Solutions and Starlab Space Stations. Since 2019, we have accomplished significant achievements in each of these segments, including the successful deployment of first-of-its-kind missile defense maneuvering capabilities, the development of groundbreaking space technology and the selection by NASA to develop a replacement for the ISS… Since 2019, we have executed and successfully vertically and horizontally integrated seven acquisitions, and have grown our revenue to $144.2 million in 2024 and $34.5 million for the three months ended March 31, 2025.' Strategy (MSTR) announced that, subject to market and other conditions, it intends to conduct an initial public offering registered under the Securities Act of 1933, as amended, of 2.5M shares of Strategy's 10.00% Series A Perpetual Stride Preferred Stock, the ' STRD Stock.' Strategy intends to use the net proceeds from the offering for general corporate purposes, including the acquisition of bitcoin and for working capital. Fitness Champs filed an initial public offering of 2M ordinary shares, with selling shareholders offering an additional 1.75M shares. The company intends to apply to list its shares on the Nasdaq under the symbol 'FCHL.' The company anticipates the initial public offering price will be between $4.00-$5.00 per share. Bancroft Capital is acting as the underwriter. Chime announced that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Chime has applied to list its common stock on the Nasdaq under the ticker symbol 'CHYM.' The number of shares to be offered and the price range for the proposed offering have not yet been determined. Morgan Stanley, Goldman Sachs and J.P. Morgan will act as lead book-running managers for the proposed offering. Barclays will act as an additional book-running manager. Evercore ISI, UBS Investment Bank, Deutsche Bank Securities, Piper Sandler and Wolfe Nomura Alliance will act as bookrunners. William Blair, Canaccord Genuity, Keefe, Bruyette & Woods, First Citizens Capital Securities and Texas Capital Securities will act as co-managers. Chime is a financial technology company. Happy City filed with the SEC for an initial public offering of 1M Class A ordinary shares of Happy City Holdings Limited, representing 14.29% of the Class A ordinary shares following completion of the offering. The company expects the initial public offering price will be between $5.00 and $7.00 per Class A share and notes it has reserved the symbol 'HCHL' for purpose of listing its Class A ordinary shares on the Nasdaq Capital Market. Odyssey Therapeutics has filed with the SEC for an initial public offering of shares of common stock. The company has applied to list its common stock on the Nasdaq Capital Market under the trading symbol 'ODTX.' The prospectus filed with the SEC states, 'Odyssey is a clinical-stage biopharmaceutical company led by a team and board of drug hunters seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases… Our most advanced programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, for which we intend to commence a Phase 2a monotherapy trial for ulcerative colitis, or UC, in the first quarter of 2025 and a Phase 2a combination trial with vedolizumab in the first half of 2026, and two preclinical programs: a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.' OTHER IPO NEWS: Dubai party hotel operator FIVE Holdings is considering listing in London or New York, three people with knowledge of the matter said, Reuters' Hadeel Al Sayegh and Federico Maccioni report. The company, which owns the Pacha hotel and nightclub, has been exploring an initial public offering in Dubai, it has said. Chairman and founder Kabir Mulchandani said last year the company was worth up to $3B and was considering a dual listing. He did not name possible locations, the authors note.
Los Angeles Times
6 hours ago
- Los Angeles Times
Netflix director Jay Hoag fails to win reelection to board
Netflix Inc. shareholders overwhelmingly rejected the reelection of venture capitalist Jay Hoag to the board of the streaming company after he was called out for failing to attend enough meetings. Hoag, a founding general partner of Menlo Park, California-based TCV, received 71.4 million votes backing his reelection and 259.9 million votes against, according to a Netflix filing Friday. The proxy adviser ISS had urged investors to reject the nomination, saying Hoag didn't attend enough board meetings last year. The board didn't disclose a reason, ISS said. Netflix said he attended two of the four meetings. Hoag served as the company's lead independent director and was chair of the board's nominating and governance committee, according to company filings. He has been a Netflix director since 1999. In accordance with Netflix policy, Hoag offered his resignation on June 5. The board plans to respond in 90 days. Netflix declined to elaborate beyond the filing. In April, the company revealed he planned to sell 127,000 shares of its stock. Shares of Netflix fell less than 1% to $1,241.48 Friday in New York. They have gained 39% this year. Golum writes for Bloomberg.
